Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter?

Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter?

Background Elderly ovarian cancer (OC) patients are more likely to be managed suboptimally, with worse clinical outcomes as a result. Strategies to decrease morbidity are lacking. Methodology: Consecutive patients with advanced stage OC (IIIC-IV) who were managed in our center between January 2016 a...

Full description

Bibliographic Details
Main Authors:	Ciro Pinelli, Matteo Morotti, Jvan Casarin, Roberto Tozzi, Fabio Ghezzi, Vasileios K. Mavroeidis, Moiad Alazzam, Hooman Soleymani majd
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-08-01
Series:	Journal of Investigative Surgery
Subjects:	cpet debulking surgery elderly neoadjuvant chemotherapy ovarian cancer morbidity
Online Access:	http://dx.doi.org/10.1080/08941939.2020.1733146

Similar Items

The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian Cancer
by: Ciro Pinelli, et al.
Published: (2021-08-01)

Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer
by: Kazuki Takasaki, et al.
Published: (2024-08-01)

Optimal debulking surgery in ovarian cancer patients: MRI may predict the necessity of rectosigmoid resection
by: Xiaofang Zhao, et al.
Published: (2024-06-01)

Serum Albumin as a Predictor of Survival after Interval Debulking Surgery for Advanced Ovarian Cancer (AOC): A Retrospective Study
by: Dairui Dai, et al.
Published: (2022-02-01)

Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction
by: Mackenzie Cummings, et al.
Published: (2022-04-01)

Complete Laparoscopic Interval Debulking Surgery for Advanced Ovarian Cancer Achieves Similar Survival Outcomes to Open Approach: A Propensity-Matched Study
by: Lise Lecointre, et al.
Published: (2022-06-01)

NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
by: A. E. Solopova, et al.
Published: (2016-09-01)

Perspectives on Ovarian Cancer 1809 to 2022 and Beyond
by: Frank G. Lawton, et al.
Published: (2022-03-01)

Risk factors of major intraoperative blood loss at primary debulking surgery for ovarian cancer
by: Sha Dou, et al.
Published: (2022-03-01)

Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024-05-01)

Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer
by: Jennifer Wolf, et al.
Published: (2024-02-01)

Prognostic Significance of Chemotherapy Response Score in Patients Undergoing Interval Debulking Surgery and Attained Complete Cytoreduction for High-Grade Serous Tubal and Ovarian Carcinoma
by: Anjana J. Santhamma, et al.

How I do it: Radical debulking of lower extremity end-stage lymphedema
by: Kuldeep Singh, MD, RPVI, FACS, et al.
Published: (2023-09-01)

Construction of a nomogram model for predicting the outcome of debulking surgery for ovarian cancer on the basis of clinical indicators
by: Yuanyuan Si, et al.
Published: (2024-07-01)

CA-125 elimination rate constant K (KELIM) as a promising predictor of complete cytoreduction after neoadjuvant chemotherapy in advanced ovarian cancer patients: a retrospective study from two Chinese hospitals
by: Cheng Li, et al.
Published: (2024-05-01)

Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients
by: Alberto Farolfi, et al.
Published: (2023-08-01)

Association between alteration of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, cancer antigen-125 and surgical outcomes in advanced stage ovarian cancer patient who received neoadjuvant chemotherapy
by: Ponganun Tuntinarawat, et al.
Published: (2024-04-01)

Critical Analysis of Advanced High-Grade Serous Epithelial Ovarian Cancer in Women: An Experience of 100 Cases from a Regional Cancer Center in Northeast India
by: Debabrata Barmon, et al.
Published: (2023-10-01)

Efficacy and safety of en-bloc resection versus debulking for spinal tumor: a systematic review and meta-analysis
by: Kai Zhang, et al.
Published: (2024-08-01)

Preoperative serum level of CA153 and a new model to predict the sub-optimal primary debulking surgery in patients with advanced epithelial ovarian cancer
by: Yue Jia, et al.
Published: (2024-02-01)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
by: Pravesh Dhiman, et al.
Published: (2022-07-01)

Biomarkers for the surgical treatment of ovarian cancer
by: Rongyu Liu, et al.
Published: (2025-03-01)

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial
by: Jimmy Belotte, et al.
Published: (2024-05-01)

Predicting the outcome of cytoreductive surgery in patients with advanced ovarian cancer
by: M. G. Yakovleva, et al.
Published: (2023-06-01)

Provisional resection of the nutrient artery in free anterolateral thigh flap debulking surgery
by: Yuta Izawa, et al.
Published: (2024-03-01)

Does the Performance of Splenectomy as Part of Cytoreductive Surgery Carry a Worse Prognosis Than in Patients Not Receiving Splenectomy? A Propensity Score Analysis and Review of the Literature
by: James Davies, et al.
Published: (2022-01-01)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
by: Liqiang Li, et al.
Published: (2022-09-01)

Mediastinal Metastasis Isolated in Ovarian Cancer: A Systematic Review
by: Victoria Psomiadou, et al.
Published: (2024-08-01)

Histopathologic Evaluation of Atypical Fibroxanthoma or Pleomorphic Dermal Sarcoma Debulk Specimen from Mohs Surgery: A Requirement for Their Proper Distinction
by: Muhammad N. Mahmood
Published: (2024-07-01)

Preoperative aerobic fitness and perioperative outcomes in patients undergoing cystectomy before and after implementation of a national lockdown
by: Nicholas Tetlow, et al.
Published: (2024-03-01)

Postoperative Complications of Upfront Ovarian Cancer Surgery and Their Effects on Chemotherapy Delay
by: Julia Heikkinen, et al.
Published: (2024-09-01)

Debulking Surgery Combined with Low-Dose Oral Prednisolone and Azathioprine for Intractable IgG4-Related Orbital Disease: A Case Report
by: Hua-Hsuan Kuo, et al.
Published: (2021-05-01)

EPITHELIAL OVARIAN CANCER. CLINICAL LECTURE
by: A. E. Solopova, et al.
Published: (2016-10-01)

Total Colectomy as a Part of Ultra-Radical Surgery for Ovarian Cancer—Short- and Long-Term Outcomes
by: Sebastian Szubert, et al.
Published: (2021-10-01)

Cardiopulmonary exercise testing in younger patients with persistent dyspnea following acute, outpatient COVID‐19 infection
by: Aaron B. Holley, et al.
Published: (2024-02-01)

Automatic Cardiopulmonary Endurance Assessment: A Machine Learning Approach Based on GA-XGBOOST
by: Jia Deng, et al.
Published: (2022-10-01)

Duodenal obstruction in a 38-year-old: Case report of an unusual ovarian cancer presentation requiring a Whipple procedure
by: Sahana Somasegar, et al.
Published: (2024-08-01)

Surgical management of anastomotic leakage related to ovarian cancer surgery: a narrative review
by: Stefano Restaino, et al.
Published: (2024-09-01)

Percentage Predicted Peak Oxygen Consumption in People With Fontan Circulation: A Rapid Systematic Scoping Review and Validation Study
by: Curtis A. Wadey, et al.
Published: (2024-09-01)

Cardiopulmonary exercise testing following acute pulmonary embolism: Systematic review and pooled analysis of global studies
by: Gabriella VanAken, et al.
Published: (2024-10-01)